Track topics on Twitter Track topics that are important to you
To treat POP, vaginal mesh is a medical device that is used to provide extra support when repairing weakened or damaged vaginal wall. Surgery can be done through the abdomen transabdominal or through the vagina transvaginal.
The global production volume of vaginal pessary was 9305 K Units in 2016. The two regions are expected to dominate both the production and consumption of vaginal pessary in the years to come. Overall, the vaginal pessary products performance is positive with the global economic recovery.
The technical barriers of vaginal pessary are high, resulting in fewer manufacturing enterprises. For vaginal pessary market, the key players are CooperSurgical, MedGyn and Personal Medical Corp. The market of vaginal Pessary is more separated, with the top four players takes 37.53% of global production market share in 2016.
In the past few years, the price of vaginal pessary has slightly increased and we expect the price will keep increase slightly as the growing of raw material cost.
The application of vaginal pessary can be broadly classified as Stress Urinary Incontinence, Severe Pelvic Organ Prolapse, and Mild Pelvic Organ Prolapse in terms of function. Mild Pelvic Organ Prolapse is the major application of vaginal pessary which takes consumption share of 75.68% in 2016. Vaginal pessary can also replace surgery in Severe Pelvic Organ Prolapse occasions. Polypropylene mesh PPM was never shown to be safe and effective for the treatment of Pelvic Organ Prolapse. Although PPM had been used for decades in the treatment of abdominal hernias, it was dangerous to assume that it would be fine to use in the vagina. Generally, vaginal pessary is the most safe way for Pelvic Organ Prolapse in the current situation.
Over the next five years, LPILP Information projects that Vaginal Pessary will register a 4.8% CAGR in terms of revenue, reach US$ 270 million by 2023, from US$ 200 million in 2017.
This report studies the global market, especially in North America, Europe, AsiaPacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Personal Medical Corp
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 forecast, like
North America United States, Canada and Mexico
AsiaPacific China, Japan, Southeast Asia, India and Korea
Europe Germany, UK, France, Italy and Russia etc.
South America Brazil, Chile, Peru and Argentina
Middle East and Africa Egypt, South Africa, Saudi Arabia
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Mild Pelvic Organ Prolapse
Stress Urinary Incontinence
Severe Pelvic Organ ProlapseNEXT ARTICLE
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...